| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/2003 | EP1347059A1 Cathepsin Y for the development of a medicament for the treatment of stroke |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347045A1 Enzyme with proteolytic activity |
| 09/24/2003 | EP1346999A2 Human secreted protein |
| 09/24/2003 | EP1346731A1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346722A1 Method for producing preparation containing bioactive substance |
| 09/24/2003 | EP1346230A2 Screening method based on tsap6 binding partners |
| 09/24/2003 | EP1346228A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 09/24/2003 | EP1346226A1 Screening method based on siah-numb interaction |
| 09/24/2003 | EP1346225A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 09/24/2003 | EP1346218A1 Tripeptide of fc gama riia |
| 09/24/2003 | EP1346065A2 Antisense modulation of src-2 expression |
| 09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 09/24/2003 | EP1346060A1 Novel molecules of the card-related protein family and used thereof |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1346056A1 Methods for the production of multimeric proteins, and related compositions |
| 09/24/2003 | EP1346053A2 Polynucleotides encoding human phosphatases |
| 09/24/2003 | EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/24/2003 | EP1346043A2 Compositions and methods relating to lung specific genes and proteins |
| 09/24/2003 | EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1346040A2 Novel nucleic acids and polypeptides |
| 09/24/2003 | EP1346038A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/24/2003 | EP1346034A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 09/24/2003 | EP1345979A2 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 09/24/2003 | EP1345969A2 Anti-cd28 antibody |
| 09/24/2003 | EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/24/2003 | EP1345964A2 Polypeptides having a triggering nk activity and biological applications |
| 09/24/2003 | EP1345963A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue |
| 09/24/2003 | EP1345962A2 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 09/24/2003 | EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 09/24/2003 | EP1345960A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau-r4 |
| 09/24/2003 | EP1345958A1 Antibodies, peptides, analogs and uses thereof |
| 09/24/2003 | EP1345957A2 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 09/24/2003 | EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 09/24/2003 | EP1345955A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 09/24/2003 | EP1345918A1 Chemical compounds |
| 09/24/2003 | EP1345694A2 A method for the manufacture of compositions containing low concentrations of salts |
| 09/24/2003 | EP1345629A2 Particles for inhalation having sustained release properties |
| 09/24/2003 | EP1345627A1 Targeted modification of intracellular compounds |
| 09/24/2003 | EP1345624A1 Induction of tolerance |
| 09/24/2003 | EP1345620A2 Stable enzymatic wound debrider |
| 09/24/2003 | EP1345619A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages |
| 09/24/2003 | EP1345618A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 09/24/2003 | EP1345617A2 Methods of modulating toll-related receptor (trr) signaling |
| 09/24/2003 | EP1345613A2 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 09/24/2003 | EP1345605A1 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 09/24/2003 | EP1345597A2 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
| 09/24/2003 | EP1345593A2 Lipid microparticles by cryogenic micronization |
| 09/24/2003 | EP1345585A1 Compositions for prevention and alleviation of skin wrinkles |
| 09/24/2003 | EP1345574A2 Improvement of graft acceptance through manipulation of thymic regeneration |
| 09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 09/24/2003 | EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity |
| 09/24/2003 | EP1123109B1 Contulakin-g, analogs thereof and uses therefor |
| 09/24/2003 | EP1117428B1 Compositions and their use for inhibiting angiogenesis |
| 09/24/2003 | EP1094829B1 Methods for accelerating bone and cartilage growth and repair |
| 09/24/2003 | EP1049709B1 Antimicrobial peptides |
| 09/24/2003 | EP1036061B1 New compounds |
| 09/24/2003 | EP0982988B1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions |
| 09/24/2003 | EP0975359B1 Use of compounds binding a cytoplasmic dipeptidase for the potentiation of the immune response |
| 09/24/2003 | EP0946190B1 Methods and compositions for stimulating neurite outgrowth |
| 09/24/2003 | EP0847278B1 Analogs of parathyroid hormone |
| 09/24/2003 | EP0845963B1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 09/24/2003 | EP0785713B1 Creating an aerosolized formulation of insulin |
| 09/24/2003 | EP0686192B1 In vitro method of enhancing fertility in the presence of inhibin/activin combinations |
| 09/24/2003 | CN1444654A Novel therapeutic molecular variants and uses thereof |
| 09/24/2003 | CN1444652A Mammalian receptor proteins, related regents and methods |
| 09/24/2003 | CN1444603A Low oxygen affinity mutant hemoglobins |
| 09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
| 09/24/2003 | CN1444601A Regulating lipid levels via the Zmaxl or HBM gene |
| 09/24/2003 | CN1444600A Use of ADNF polypeptides for enhancing learning and memory |
| 09/24/2003 | CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons |
| 09/24/2003 | CN1444477A Thrombopoietin mimetics |
| 09/24/2003 | CN1444475A Preparation with vascular protective and anti-oxidative effect and use thereof |
| 09/24/2003 | CN1444474A Nonoral preparation having three-layer structure |
| 09/24/2003 | CN1444469A Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 09/24/2003 | CN1443850A Method for preparing recombinant human CTLA4 extracellular region protein, and obtained product and application |
| 09/24/2003 | CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition |
| 09/24/2003 | CN1443772A Narcissus seed glycopeptide and its application |
| 09/24/2003 | CN1443574A Ranzhi Jianfei oral preparation for reducing weight |
| 09/24/2003 | CN1443573A Recombinant human interferon alpha 2 b nose drops and its production method |
| 09/24/2003 | CN1443572A Recombinant human interferon alpha 2 b lozenge and its production method |
| 09/24/2003 | CN1443571A Bone growth factor injection and its preparation method |
| 09/24/2003 | CN1443570A Application of thymosin alpha 1 in preparation of medicine for curing burn and scald |
| 09/24/2003 | CN1121853C Pharmaceutical compositions for hardly soluble active substances |
| 09/23/2003 | US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents |
| 09/23/2003 | US6624293 Synthetic complementary DNA for controlling gene expression phenotypes such as cyclin dependent kinases in cells, used as anticarcinogenic, antisense and/or antiproliferative agents |
| 09/23/2003 | US6624290 Azapeptides useful in the treatment of Hepatitis C |
| 09/23/2003 | US6624289 Nonapeptides comprising domains of chymotrypsin used as anticoagulants or thrombolytic agents |
| 09/23/2003 | US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers |
| 09/23/2003 | US6624287 Method for searching physiologically active substances, process for producing these substances and drugs found by the searching method |
| 09/23/2003 | US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/23/2003 | US6624147 Inhibitors of prenylated pyrophosphate consuming enzymes |
| 09/23/2003 | US6624146 MTS represents a membrane-transfer amino acid sequence; X represents a direct bond or a linker sequence; and NLS represents a nuclear localization amino acid sequence, or a pharmaceutically acceptable salt thereof for weight reduction |
| 09/23/2003 | US6624144 Matrix metalloproteinase inhibitors and down-regulators |
| 09/23/2003 | US6624143 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/23/2003 | US6624142 Trimethyl lock based tetrapartate prodrugs |
| 09/23/2003 | US6624141 Protamine fragment compositions and methods of use |